Technology
New On Robinhood
Health

Axonics Modulation

$23.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.26 (5.66%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AXNX and other stocks, options, ETFs, and crypto commission-free!

About

Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). Read More It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.

Employees
87
Headquarters
Irvine, California
Founded
2012
Market Cap
619.54M
Price-Earnings Ratio
Dividend Yield
Average Volume
166.47K
High Today
$23.94
Low Today
$21.95
Open Price
$22.24
Volume
69.95K
52 Week High
$24.41
52 Week Low
$11.95

Collections

Technology
New On Robinhood
Health
Medical
2018 IPO
US
North America

News

Simply Wall StMar 14

How Financially Strong Is Axonics Modulation Technologies, Inc. (NASDAQ:AXNX)?

Investors are always looking for growth in small-cap stocks like Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), with a market cap of US$574m. However, an important fact which most ignore is: how financially healthy is the business? Given that AXNX is not presently profitable, it’s crucial to evaluate the current state of its operations and pathway to profitability. We’ll look at some basic checks that can form a snapshot the company’s financial strength. Nevertheless, potential investors would need to...

59

Earnings

-$2.67
-$1.89
-$1.12
-$0.34
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 10, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.